SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SSgA Active Trust - SPDR S&P 500 ETF Trust

SPY is trending as traders closely monitor the government shutdown vote, anticipating market impacts. Community discussions revolve around whether the reopening is already priced in, while some express concern over potentially delayed economic data. There's also chatter about the possible release of Epstein files and how that may impact the markets.

Invesco Capital Management LLC - Invesco QQQ Trust Series 1

QQQ is trending as traders react to the House passing a bill to end the government shutdown and anticipate Trump's signature. While some community members are optimistic about a potential rally, others believe the news is already priced in and are watching for a "sell the news" event or a sector rotation. There is also a lot of talk about a possible AI bubble and the potential impact of delayed economic data.

JasmyCoin is based on the ERC 20 standard. The token can also be used by an unspecified number of individuals and businesses to transfer tokens using digital devices as proof of value exchange or payment for services. By not limiting its usability, the token can have a wide range of purposes.

JasmyCoin

JASMY is trending amidst mixed sentiment regarding its future and the impact of the recently launched Janction (JCT) token; some community members express concerns about resource allocation between the two projects, while others view JCT as beneficial to the broader Jasmy ecosystem and driving demand. Discussions also include technical analysis, price predictions, and frustration with the token's performance in a fluctuating market.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+ and TMTG News. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

DJT is trending amid discussions surrounding newly released Epstein emails and Trump's alleged connections, sparking renewed scrutiny and debate. Community members are actively discussing the implications of these revelations, with some questioning Trump's past associations and others defending him against the allegations. The stock's performance is being closely watched in light of these developments.

Circle Internet Group, Inc. is a financial technology company that enables businesses of all sizes to harness the power of digital currencies and public blockchains for payments, commerce and financial applications worldwide. The company was founded by Jeremy J. Allaire and Patrick Sean Neville in August 2013 and is headquartered in New York, NY.

Circle Internet Group Inc. - Ordinary Shares - Class A

Circle

CRCL is trending downwards as investors discuss an upcoming lockup expiration, potentially leading to increased selling pressure. Despite some bullish sentiment and Cathie Wood's ARK Invest adding shares, the community is wary of potential insider selling. Discussions also involve the broader stablecoin market and regulatory landscape, with some comparing CRCL to other hyped IPOs.

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

Novavax, Inc.

Novavax Inc

Novavax is trending due to activist investor Shah Capital pushing for the company's sale, citing management's "profound lack of competence" and expressing frustration over Novavax's minuscule COVID vaccine market share. The community is echoing Shah's concerns, criticizing CEO John Jacobs' leadership and advocating for a sale to a larger pharmaceutical company. Discussions center on whether a sale is the best path forward, given the company's struggles in the competitive vaccine market.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MLTX is trending as investors discuss the company's upcoming presentation at the Inflammatory Skin Disease Summit and a confirmed FDA meeting in December, both seen as potential catalysts. Bullish sentiment is fueled by significant institutional ownership and recent data suggesting a best-in-class profile for their drug, SLK, despite a recent public offering.

BigBear.ai Holdings, Inc. engages in data-driven decision dominance and advanced analytics that provide its customers with a competitive advantage in a world driven by data that is growing in terms of volume, variety, and velocity. The firm operationalizes artificial intelligence and machine learning at scale through its end-to-end data analytics platform. It deploys its observe, orient and dominate products to customers throughout the defense, intelligence, and commercial markets. The company was founded in 2020 and is headquartered in McLean, VA.

BigBear.ai Holdings Inc

BigBear.ai is trending as community members discuss its potential as the next Palantir, fueled by a recent acquisition and Q3 earnings. Bullish sentiment is further driven by the anticipation of government contracts, particularly related to border security, following the potential government reopening. Discussions also focus on high short interest and potential for a short squeeze.

The Walt Disney Co. engages in the business of international family entertainment and media enterprise. It owns and operates television and radio production, distribution and broadcasting stations, direct-to-consumer services, amusement parks, and hotels. It operates through the following business segments: Disney Entertainment, ESPN, and Disney Parks, Experiences, and Products. The company was founded by Walter Elias Disney on October 16, 1923 and is headquartered in Burbank, CA.

Walt Disney Co (The)

Walt Disney Co

Disney ($DIS) is trending due to upcoming earnings, with community members actively discussing potential catalysts and market sentiment. Bullish sentiment is fueled by the possibility of a solid earnings beat and positive momentum, while others express concerns about various challenges and the stock's historical performance. Discussions also include Disney's streaming strategy, theme park performance, and broader market context, as well as some chatter about a dispute with Youtube TV.

Creative Media & Community Trust Corp. is a real estate investment trust that seeks to own, operate, and develop premier multifamily and creative office assets in vibrant and emerging communities throughout the United States. It operates through the following segments: Office, Hotel, and Lending. The Office segment consists of the rental of office space and other tenant services, including tenant reimbursements, parking, and storage space rental. The Hotel segment involves the operation of hotel properties. The Lending segment focuses on loans to small businesses. The company was founded in 1993 and is headquartered in Dallas, TX.

Creative Media & Community Trust

Creative Media & Community Trust is trending due to the announced sale of its lending division for $44 million, leading to discussions about its potential impact on the company's financials. The community is actively analyzing the low float and potential for a short squeeze, with some traders setting ambitious price targets. Speculation surrounds the company's future strategy and whether the proceeds will benefit shareholders.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Coherus Oncology (NASDAQ:CHRS) Raised to Hold at Wall Street Zen

Wall Street Zen raised shares of Coherus Oncology from a "sell" rating to a "hold" rating in a research note on Saturday...

Coherus Oncology (NASDAQ:CHRS) Announces Quarterly Earnings Results

Coherus Oncology (NASDAQ:CHRS - Get Free Report) posted its earnings results on Thursday. The biotechnology company reported ($0.33) earnings per share for the quarter, topping analysts' consensus...

Coherus Oncology (CHRS) Reports Q3 Loss, Lags Revenue Estimates

Coherus Oncology (CHRS) delivered earnings and revenue surprises of -3.13% and -5.23%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Illumina (ILMN) Beats Q3 Earnings and Revenue Estimates

Illumina (ILMN) delivered earnings and revenue surprises of +15.52% and +1.73%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Coherus Oncology (CHRS) Reports Q2 Loss, Beats Revenue Estimates

Coherus Oncology (CHRS) delivered earnings and revenue surprises of -9.68% and +1.32%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Arcus Biosciences, Inc. (RCUS) Reports Break-Even Earnings for Q2

Arcus Biosciences (RCUS) delivered earnings and revenue surprises of +100.00% and +593.24%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Strength Seen in Krystal Biotech (KRYS): Can Its 4.2% Jump Turn into More Strength?

Krystal Biotech (KRYS) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

Coherus BioSciences (CHRS) Reports Q1 Loss, Lags Revenue Estimates

Coherus Biosciences price target lowered by $2 at H.C. Wainwright, here's why

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

Commit To Purchase Coherus BioSciences At $2, Earn 42.6% Annualized Using Options

Investors eyeing a purchase of Coherus BioSciences Inc (CHRS) shares, but cautious about paying the going market price of 2.37/share, might benefit from considering selling puts among the...

Coherus Oncology, Inc. is a commercial-stage biopharmaceutical company, which engages in the development and commercialization of biosimilar therapeutics. Its products include UDENYCA and LOQTORZI. The company was founded by Dennis M. Lanfear, Stuart E. Builder, Dr. Alan Herman, Doug Farrar and Steve Glover in September 2010 and is headquartered in Redwood City, CA.

Coherus Oncology Inc.

Will NVIDIA ($NVDA) beat quarterly earnings? 
 
*Powered by Polymarket

Stocktwits

) beat quarterly earnings? 
 
*Powered by Polymarket

CHRS
Coherus Biosciences Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest CHRS News

CHRSCoherus Biosciences Inc